Amin RM, Puvanesarajah V, Chaudhry YP, Best MJ, Rao SS, Frank SM, Hasenboehler EA. Reducing unnecessary crossmatching for hip fracture patients by accounting for preoperative hemoglobin concentration. World J Orthop 2021; 12(5): 292-300 [PMID: 34055586 DOI: 10.5312/wjo.v12.i5.292]
Corresponding Author of This Article
Erik A Hasenboehler, MD, Assistant Professor, Department of Orthopaedics, Johns Hopkins School of Medicine, 4940 Eastern Avenue, Baltimore, MD 21205, United States. ehasenb1@jhmi.edu
Research Domain of This Article
Orthopedics
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Orthop. May 18, 2021; 12(5): 292-300 Published online May 18, 2021. doi: 10.5312/wjo.v12.i5.292
Reducing unnecessary crossmatching for hip fracture patients by accounting for preoperative hemoglobin concentration
Raj M Amin, Varun Puvanesarajah, Yash P Chaudhry, Matthew J Best, Sandesh S Rao, Steven M Frank, Erik A Hasenboehler
Raj M Amin, Department of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA 94305, United States
Varun Puvanesarajah, Sandesh S Rao, Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States
Yash P Chaudhry, Department of Orthopaedic Surgery, Philadelphia College of Osteopathic Medicine, Philadelphia, PA 19122, United States
Matthew J Best, Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MD 02114, United States
Steven M Frank, Department of Anesthesiology, Critical Care Medicine, Baltimore, MD 21205, United States
Erik A Hasenboehler, Department of Orthopaedics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States
Author contributions: Amin RM, Puvanesarajah V, Best MJ, and Hasenboehler EA designed the research study; Amin RM, Chaudhry YP, and Rao SS analyzed the data; Amin RM, Chaudhry YP, Puvanesarajah V, Frank SM, and Hasenboehler EA wrote and edited the manuscript; All authors have read and approve the final manuscript.
Institutional review board statement: Institutional review board approval was obtained for this study (IRB CR00016216).
Conflict-of-interest statement: Hasenboehler EA is a paid consultant for DePuy Synthes Trauma. He receives grant support as well as a grant for a research fellow from DePuy Synthes Trauma. He is also a paid lecturer and faculty for AO North America Trauma and has stock ownership in Summit Med Ventures. Other authors have no conflict-of-interest to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Erik A Hasenboehler, MD, Assistant Professor, Department of Orthopaedics, Johns Hopkins School of Medicine, 4940 Eastern Avenue, Baltimore, MD 21205, United States. ehasenb1@jhmi.edu
Received: January 16, 2021 Peer-review started: January 16, 2021 First decision: January 24, 2021 Revised: February 18, 2021 Accepted: April 9, 2021 Article in press: April 9, 2021 Published online: May 18, 2021 Processing time: 115 Days and 19 Hours
ARTICLE HIGHLIGHTS
Research background
Blood product utilization is becoming increasingly scrutinized in orthopaedic surgery as restrictive transfusion triggers and conservative blood management strategies have become more common.
Research motivation
As transfusion frequency decreases through implementation of restrictive blood management practices, a rethinking of preoperative blood product allocation is required. Rather than using standardized maximum surgical blood order schedules (MSBOS), we wanted to investigate the ideal type and cross ratios for hip fracture patients while accounting for preoperative hemoglobin values.
Research objectives
The aims of this study were to characterize and compare the ideal 2:1 crossmatch to transfusion ratio in hip fracture patients before and after the implementation of a restrictive blood management policy at our institution.
Research methods
A retrospective review was conducted of all operatively treated hip fractures at our institution from January 2013 through May 2017. Cases were split up based on whether they occurred before or after implementation of a patient blood management (PBM) program (January 2015). Receiver operating curve analyses were used to determine the preoperative hemoglobin levels predicting 50% transfusion events in the pre- and post-PBM cohorts.
Research results
Implementation of the PBM resulted in a significant decrease in transfusion requirements from the pre- to post-PBM cohorts (51% vs 33%, P < 0.0001). Additionally, the post-PBM cohort was much less likely to receive multiple transfusions. Compared to the pre-PBM cohort, the post-PBM cohort had a much lower preoperative hemoglobin value that predicted a 50% transfusion probability.
Research conclusions
In order to more appropriately allocate blood product resources, hip fracture MSBOS should be updated to reflect current restrictive transfusion strategies and should consider preoperative patient hemoglobin values.
Research perspectives
Further study at other institutions is warranted to validate the generalizability of our findings. To help conserve resources, additional MSBOS studies are warranted in other orthopaedic trauma surgery procedures as well.